These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20812302)

  • 1. A robust weighted Kaplan-Meier approach for data with dependent censoring using linear combinations of prognostic covariates.
    Hsu CH; Taylor JM
    Stat Med; 2010 Sep; 29(21):2215-23. PubMed ID: 20812302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of accelerated failure time data with dependent censoring using auxiliary variables via nonparametric multiple imputation.
    Hsu CH; Taylor JM; Hu C
    Stat Med; 2015 Aug; 34(19):2768-80. PubMed ID: 25999295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin.
    Kawahara T; Shinozaki T; Matsuyama Y
    BMC Med Res Methodol; 2020 Jul; 20(1):204. PubMed ID: 32736528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
    Willems S; Schat A; van Noorden MS; Fiocco M
    Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of colorectal adenoma recurrence with dependent censoring.
    Hsu CH; Long Q; Alberts DS
    BMC Med Res Methodol; 2009 Sep; 9():66. PubMed ID: 19788750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Model selection for survival individualized treatment rules using the jackknife estimator.
    Honvoh GD; Cho H; Kosorok MR
    BMC Med Res Methodol; 2022 Dec; 22(1):328. PubMed ID: 36550398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved precision in the analysis of randomized trials with survival outcomes, without assuming proportional hazards.
    Díaz I; Colantuoni E; Hanley DF; Rosenblum M
    Lifetime Data Anal; 2019 Jul; 25(3):439-468. PubMed ID: 29492746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weighted Kaplan-Meier estimators for two-stage treatment regimes.
    Miyahara S; Wahed AS
    Stat Med; 2010 Nov; 29(25):2581-91. PubMed ID: 20799259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond D'Amico risk classes for predicting recurrence after external beam radiotherapy for prostate cancer: the Candiolo classifier.
    Gabriele D; Jereczek-Fossa BA; Krengli M; Garibaldi E; Tessa M; Moro G; Girelli G; Gabriele P;
    Radiat Oncol; 2016 Feb; 11():23. PubMed ID: 26911291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of colorectal adenoma recurrence data subject to informative censoring.
    Hsu CH; Taylor JM; Long Q; Alberts DS
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):712-7. PubMed ID: 19240239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Weighted estimation of the accelerated failure time model in the presence of dependent censoring.
    Cho Y; Ghosh D
    PLoS One; 2015; 10(4):e0124381. PubMed ID: 25909753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment PSA: a joint modeling approach.
    Proust-Lima C; Taylor JM
    Biostatistics; 2009 Jul; 10(3):535-49. PubMed ID: 19369642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival analysis using auxiliary variables via non-parametric multiple imputation.
    Hsu CH; Taylor JM; Murray S; Commenges D
    Stat Med; 2006 Oct; 25(20):3503-17. PubMed ID: 16345047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiply robust estimator for the difference in survival functions using pseudo-observations.
    Wang C; Wei K; Huang C; Yu Y; Qin G
    BMC Med Res Methodol; 2023 Oct; 23(1):247. PubMed ID: 37872495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A profile conditional likelihood approach for the semiparametric transformation regression model with missing covariates.
    Chen HY; Little RJ
    Lifetime Data Anal; 2001 Sep; 7(3):207-24. PubMed ID: 11677827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cox regression analysis with missing covariates via nonparametric multiple imputation.
    Hsu CH; Yu M
    Stat Methods Med Res; 2019 Jun; 28(6):1676-1688. PubMed ID: 29717943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Consistent estimation of the expected Brier score in general survival models with right-censored event times.
    Gerds TA; Schumacher M
    Biom J; 2006 Dec; 48(6):1029-40. PubMed ID: 17240660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment 3T multiparametric MRI staging predicts for biochemical failure in high-risk prostate cancer treated with combination high-dose-rate brachytherapy and external beam radiotherapy.
    Hegde JV; Demanes DJ; Veruttipong D; Raince J; Park SJ; Raman SS; Nickols NG; King CR; Kishan AU; Steinberg ML; Kamrava M
    Brachytherapy; 2017; 16(6):1106-1112. PubMed ID: 28807747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Factors for Biochemical Recurrence More than 10 Years after Radical Prostatectomy.
    Liesenfeld L; Kron M; Gschwend JE; Herkommer K
    J Urol; 2017 Jan; 197(1):143-148. PubMed ID: 27418452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.